Previous close | 12.95 |
Open | 12.69 |
Bid | 11.66 x 0 |
Ask | 11.69 x 0 |
Day's range | 11.03 - 13.70 |
52-week range | 3.74 - 26.00 |
Volume | |
Avg. volume | 2,013,329 |
Market cap | 1.054B |
Beta (5Y monthly) | 1.63 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), a world-leading diversified cannabis company, celebrates the German government's final approval legalizing cannabis, as well as advancing a clear victory for enhanced medical cannabis access.
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today announced that independent proxy advisory firm Glass Lewis & Co. ("Glass Lewis"), in its report issued on Canopy Growth's special meeting of shareholders scheduled for April 12, 2024, recommended that Canopy Growth shareholders (the "Canopy Shareholders") vote in favour of the previously announced special resolution authorizing an amendment to the Company's articles of incorporation, as amended (the "Ame
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today announced additional details with respect to the previously announced special resolution to be voted on by the shareholders of Canopy Growth (the "Canopy Shareholders") authorizing an amendment to the Company's articles of incorporation, as amended (the "Amendment Proposal"), in order to: (i) create and authorize the issuance of an unlimited number of a new class of non-voting and non-participating excha